Second Injunction Issued Against CosMx PLEASANTON, Calif.  — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court (“UPC”) issued a preliminary injunction against NanoString Technologies, Inc. (Nasdaq: NSTG) for infringing European Patent 4 108 782 B1 (“the EP 782 patent,” docket No 459746/2023). The preliminary injunction, issued […]

NanoString Will Immediately Appeal Preliminary Injunction Temporarily Blocking NanoString’s Ability to Market and Sell CosMx Spatial Molecular Imager Products for RNA Detection within UPC Member Countries in Europe SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on today’s order from the European Unified […]

The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics Caption: The patented technology forms part of a new multi-omic platform, pictured, that accelerates biomedical research and transforms in vitro diagnostics. CAMBRIDGE, UK –  SMi Systems has secured a patent from the UK Intellectual Property Office (IPO) for the single-molecule imaging technologies that […]

U.S. issued patent expands BioSkryb’s IP portfolio to four granted patents in key geographic markets worldwide DURHAM, N.C. – BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, today announced the issuance of a composition of matter patent, US Patent 11,643,682 by the U.S. Patent […]

PhenomeX stands behind its ground-breaking Beacon® technology that advances human health globally; remains confident it will prove its case in court EMERYVILLE, Calif. — PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the series of lawsuits filed by AbCellera in 2020 will now proceed in litigation. AbCellera contends that PhenomeX’s Beacon® platform infringes […]

HERCULES, Calif., & VENLO, the Netherlands —  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), today announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing agreement relating to digital […]

PTAB rejects request by Berkeley Lights to reconsider its decision denying Berkeley’s argument that AbCellera’s U.S. patent is invalid VANCOUVER, British Columbia — AbCellera (Nasdaq: ABCL) announced that the United States Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTAB) has denied a rehearing request in an Inter Partes Review (IPR) filed by Berkeley […]

10x and Harvard now must defend against allegations that they “are pursuing an ill-gotten monopoly by enforcing patents that are subject to a requirement that they be licensed non-exclusively” SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, provided comments on yesterday’s order of the United […]

10x and President and Fellows of Harvard ordered to answer counterclaims asserted by Vizgen CAMBRIDGE, Mass. – Vizgen, Inc. (“Vizgen” or the “Company”), a life science leader dedicated to improving human health by visualizing single-cell spatial genomics information, today noted the order on Vizgen’s counterclaims against Plaintiffs 10x Genomics, Inc. (“10x”) and Harvard College (“Harvard”) […]

PALO ALTO, Calif. — An Administrative Law Judge at the United States International Trade Commission (USITC) has announced the termination of the Section 337 investigation involving certain biolayer interferometers and components. In October 2022, Sartorius BioAnalytical Instruments, Inc. lodged a complaint with the USITC against Gator Bio, Inc., alleging the infringement of four US patents. After […]